Nika Pharmaceuticals Inc (NIKA) Financial Statements
Nika Pharmaceuticals Inc Financial Overview
Nika Pharmaceuticals Inc's market cap is currently $368.09M. The company's EPS TTM is $0.00; its P/E ratio is -4711.57; Nika Pharmaceuticals Inc has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -76.40K | $ -95.79K | $ -64.83K | $ -3.18M | $ -14.71K |
| EBITDA | $ -76.40K | $ -95.79K | $ -64.83K | $ -3.18M | $ -14.71K |
| Net Income | $ -76.40K | $ -95.79K | $ -64.83K | $ -3.18M | $ -14.71K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.89K | $ 2.08K | $ 19.60K | $ 864.00 | $ 399.00 |
| Total Assets | $ 21.00K | $ 17.93K | $ 19.60K | $ 864.00 | $ 399.00 |
| Total Debt | $ 0.00 | $ 239.16K | $ 101.75K | $ 18.18K | $ 24.02K |
| Net Debt | $ -1.89K | $ 237.08K | $ 82.15K | $ 17.32K | $ 23.62K |
| Total Liabilities | $ 318.62K | $ 239.16K | $ 101.75K | $ 18.18K | $ 24.02K |
| Stockholders' Equity | $ -297.63K | $ -221.23K | $ -82.15K | $ -17.32K | $ -23.62K |
| Cash Flow | |||||
| Free Cash Flow | $ -79.65K | $ -139.08K | $ -64.83K | $ -33.72K | $ -14.71K |
| Operating Cash Flow | $ -79.65K | $ -154.93K | $ -64.83K | $ -33.72K | $ -14.71K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 79.46K | $ 137.42K | $ 83.56K | $ 34.18K | $ 13.50K |
Currency in USD
